Sponsor of the Day:
Jerkmate
https://www.globenewswire.com/news-release/2026/02/23/3242481/33090/en/Axsome-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html
Axsome Therapeutics Reports Fourth Quarter and Full Year
Feb 23, 2026 - Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growth AUVELITY®...
reports fourth quarteraxsome therapeuticsfull year
https://www.axsome.com/conditions/fibromyalgia/
Fibromyalgia - Axsome Therapeutics
Jan 26, 2025 - Approximately 5 million Americans are estimated to suffer from fibromyalgia. Learn about Axsome's work in fibromyalgia and the unmet needs of patients.
axsome therapeuticsfibromyalgia
https://www.axsome.com/axs-portfolio/products/
Products Overview - Axsome Therapeutics
Jan 25, 2025 - Get information on Axsome products that are currently in-market, developed to find new ways to solve treatment gaps in CNS conditions.
products overviewaxsome therapeutics
https://www.axsome.com/science/
Our Science - Axsome Therapeutics
Jan 24, 2025 - The way we see it, every unmet need is a breakthrough waiting to happen. Learn more about the science of Axsome.
axsome therapeuticsscience
https://www.axsome.com/axs-portfolio/pipeline/
AXS Pipeline - Axsome Therapeutics
Jan 29, 2026 - Our pipeline includes five differentiated clinical-stage CNS therapies targeting significant and growing markets. View the full pipeline of product candidates.
axsome therapeuticspipeline
https://www.biospace.com/press-releases/axsome-therapeutics-acquires-selective-pde10a-inhibitor-balipodect-for-the-treatment-of-schizophrenia-and-other-neuropsychiatric-conditions
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of...
axsome therapeuticsacquiresselectiveinhibitortreatment
https://www.axsome.com/conditions/alzheimers-disease-agitation/
Alzheimer's Disease Agitation - Axsome Therapeutics
Jan 27, 2025 - Agitation is reported in about 70% of people living with Alzheimer's disease (AD). Learn about Axsome's work in agitation in patients with AD, key facts and...
axsome therapeuticsalzheimerdiseaseagitation
https://www.axsome.com/
Homepage - Axsome Therapeutics
Jan 31, 2025 - We are committed to developing products that meaningfully improve the lives of patients. Axsome is developing innovative treatments including AXS-05, AXS-12,...
axsome therapeuticshomepage
https://robinhood.com/us/en/stocks/AXSM/
Axsome Therapeutics: AXSM Stock Price Quote & News | Robinhood
View the real-time AXSM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold...
stock price quoteaxsome therapeuticsnews robinhood